4.3 Article

Real-World Patient Experience on the Path to Diagnosis of Ankylosing Spondylitis

期刊

RHEUMATOLOGY AND THERAPY
卷 6, 期 2, 页码 255-267

出版社

SPRINGER
DOI: 10.1007/s40744-019-0153-7

关键词

Ankylosing spondylitis; Diagnosis; Misdiagnosis; Patient experience; Real-world study

资金

  1. Novartis Pharmaceuticals Corporation

向作者/读者索取更多资源

IntroductionWe describe the journey to diagnosis of ankylosing spondylitis (AS) from the patient perspective and examine differences in this journey by sex.MethodsUS adults aged 18years with a self-reported AS diagnosis were recruited online through CreakyJoints, a patient support community, and ArthritisPower, a patient research registry. Respondents completed a web-based survey on sociodemographics, disease burden, and diagnosis history. Results were stratified by sex and time to diagnosis using two-sample t tests and (2) tests, respectively, to observe differences across the groups; P<0.05 was considered statistically significant.ResultsAmong 235 respondents, 174 (74.0%) were female. Mean (SD) ages of female and male respondents were 48.6 (10.6) and 53.1 (10.3) years, respectively. From the time respondents began seeking medical attention, 87 were diagnosed within 1year, 71 in 2-9years, and 77 after 10years. Symptoms that led respondents to seek treatment were back pain (73.2%) and joint pain (63.8%); fatigue and difficulty sleeping were more common among respondents with longer times to diagnosis. During the diagnosis process, men with AS tended to receive quicker AS diagnosis compared with women. Overall, commonly reported initial diagnoses among respondents with longer time to AS diagnosis included back problems and psychosomatic disorders. Significantly more women reported misdiagnoses of fibromyalgia (20.7 vs. 6.6%) and psychosomatic disorders (40.8 vs. 23.0%) compared with men.ConclusionsDiagnosis delays and misdiagnoses were common among respondents with AS. Increasing awareness about AS among referring providers may minimize diagnosis delay.FundingNovartis Pharmaceuticals Corporation.Plain Language SummaryPlain language summary available for this article.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据